November 06, 2015
Novartis Pharmaceuticals Corp. and the co-owner of some of its patents filed a pair of suits in Delaware federal court Thursday over generic-drug makers Dr. Reddy's Laboratories Ltd. and Amneal Pharmaceuticals Inc.'s plans to make and market generic versions of Novartis' Exelon patch used to treat dementia associated with Parkinson's or Alzheimer's disease.